Related references
Note: Only part of the references are listed.Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
Mechanisms and clinical implications of hepatocyte lipoapoptosis
Sophie C. Cazanave et al.
CLINICAL LIPIDOLOGY (2010)
PF-03491390 PAN-CASPASE INHIBITOR DECREASES LIVER INJURY AND FIBROSIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)
F. J. Barreyro et al.
JOURNAL OF HEPATOLOGY (2010)
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2010)
Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis
Rafal P. Witek et al.
HEPATOLOGY (2009)
Caspases - An update
Indrajit Chowdhury et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2008)
The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity
ZhengZheng Li et al.
HEPATOLOGY (2008)
Caspases: Structure-Guided Design of Drugs to Control Cell Death
Irene T. Weber et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Caspases in apoptosis and beyond
J. Li et al.
ONCOGENE (2008)
Prevalence of fatty liver in children and adolescents
Jeffrey B. Schwimmer et al.
PEDIATRICS (2006)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
NF-κB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis
A Dela Peña et al.
GASTROENTEROLOGY (2005)
Nonalcoholic fatty liver disease in the pediatric population: a review
A Wieckowska et al.
CURRENT OPINION IN PEDIATRICS (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Hepatic steatosis: A mediator of the metabolic syndrome. Lessons from animal models
M den Boer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Nonalcoholic steatohepatitis: Histologic features and clinical correlations with 30 blinded biopsy specimens
EM Brunt et al.
HUMAN PATHOLOGY (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
AE Feldstein et al.
HEPATOLOGY (2004)
Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice
AE Feldstein et al.
JOURNAL OF HEPATOLOGY (2003)
Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis
AE Feldstein et al.
GASTROENTEROLOGY (2003)
Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis
A Canbay et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
